Claudio Chiarolla donne une conférence, organisée conjointement par le Centre for Commercial Law Studies de la Queen Mary University of London (Royaume-Uni) et l'Iddri, sur "New crossroads for the life sciences? Research & Development Implications of the Nagoya Protocol on Access and Benefit-?Sharing (ABS) in France and the European Union".
Présentation [en anglais] :
This public lecture will present, analyse and discuss key aspects of the ABS provisions of the draft Biodiversity Law of France, the EU draft ABS Regulation and the Nagoya Protocol, with a particular focus on their implications for the life sciences and for legal practitioners in the field of intellectual property or involved in transactions associated with the conclusion of R&D agreements in the context of complex regulatory regimes.
